Goldfish Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 5.00 Cr
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 4.48 Cr
- Satisfied Charges ₹ 2.64 Cr
- Revenue Growth 11.13%
- Profit Growth 149.61%
- Ebitda 73.75%
- Net Worth 7.19%
- Total Assets 1.18%
About Goldfish Pharma
Goldfish Pharma Private Limited (GPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 May 2008 and has a history of 16 years and eight months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹4.48 Cr. The company has closed loans amounting to ₹2.64 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dinesh Bhimireddy, Bhimireddy Jayalakshmi, and Bindhu Bhimireddy serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TG2008PTC059097
-
Company No.
059097
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 May 2008
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Goldfish Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Bhimireddy
|
Director | 12-May-2008 | Current |
|
Bhimireddy Jayalakshmi
|
Director | 08-Nov-2011 | Current |
|
Bindhu Bhimireddy
|
Director | 27-Mar-2019 | Current |
Financial Performance of Goldfish Pharma.
Goldfish Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 11.13% increase. The company also saw a substantial improvement in profitability, with a 149.61% increase in profit. The company's net worth moved up by a moderate rise of 7.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Goldfish Pharma?
In 2021, Goldfish Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.48 Cr
₹2.64 Cr
Charges Breakdown by Lending Institutions
- Others : 3.28 Cr
- Bank Of India : 1.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jun 2017 | Others | ₹3.28 Cr | Open |
| 25 Sep 2013 | Bank Of India | ₹1.20 Cr | Open |
| 29 May 2017 | Others | ₹7.56 M | Satisfied |
| 06 Jan 2015 | Dewan Housing Finance Corporation Limited | ₹1.88 Cr | Satisfied |
How Many Employees Work at Goldfish Pharma?
Unlock and access historical data on people associated with Goldfish Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Goldfish Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goldfish Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
